Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-09

Clinical Trial Update: Effectiveness of IRK-19® on Body Weight Control [NA]

View source ↗

Summary

A completed clinical trial evaluated the effectiveness of IRK-19® for body weight control in people with overweight and metabolic syndrome; results have been re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRK-19®

Snippet

Sponsor: Greenyn Biotechnology Co., Ltd. | Conditions: Overweight, Metabolic Syndrome | NA | Status: COMPLETED